---
title: "Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289327082.md"
description: "Interwell Health, the value-based care arm of Fresenius Medical Care, reported exceptional performance in the Kidney Care Choices Model in BAD HOMBURG, Germany as of June 10, 2026. The company achieved high quality ratings and witnessed a consistent increase in savings over the initial three years of the program. These positive outcomes showcase Interwell Health's commitment to delivering top-tier care and financial efficiency within the kidney care sector."
datetime: "2026-06-10T12:08:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289327082.md)
  - [en](https://longbridge.com/en/news/289327082.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289327082.md)
generator: "portal-rs"
---

# Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model

Interwell Health, the value-based care arm of Fresenius Medical Care, reported exceptional performance in the Kidney Care Choices Model in BAD HOMBURG, Germany as of June 10, 2026. The company achieved high quality ratings and witnessed a consistent increase in savings over the initial three years of the program. These positive outcomes showcase Interwell Health's commitment to delivering top-tier care and financial efficiency within the kidney care sector.

### Related Stocks

- [FME.DE](https://longbridge.com/en/quote/FME.DE.md)
- [FMS.US](https://longbridge.com/en/quote/FMS.US.md)

## Related News & Research

- [BlackRock trims Fresenius Medical Care voting rights stake to 6.63% from 7%](https://longbridge.com/en/news/297496680.md)
- [Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care | FMS Stock News](https://longbridge.com/en/news/287236647.md)
- [10:05 ETUnlock Health Launches Menopause and Medical Weight Loss Health Risk Assessments](https://longbridge.com/en/news/297199118.md)
- [XORTX discloses US$240,000 finder’s fees tied to Vectus renal program acquisition after omission](https://longbridge.com/en/news/297312983.md)
- [Teladoc’s Completed BetterHelp Trial Signals a New Phase for Digital Mental Health Investing](https://longbridge.com/en/news/297070880.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**